Context Therapeutics Inc. — Director's Dealing 2021

Oct 20, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Context Therapeutics Inc. (CNTX)
CIK: 0001842952
Period of Report: 2021-10-19

Reporting Person: Dick Evan G. (SVP of R&D)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	60552	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series Seed Preferred Stock	$		Common Stock (26587)		Direct
Stock Option (right to buy)	$11.4	2030-02-15	Common Stock (1250)		Direct

Footnotes

F1: Includes 39,659 restricted stock units which fully vest on February 24, 2023.

F2: Exercisable upon the date of grant.

F3: N/A

F4: Converts to common stock on a one for one basis.

F5: Fully vested.